Tag

Patent

MWZB Posted on IPTouring.com

MWZB is proud to announce that Ryan Pool’s article entitled, “The Inherency Doctrine and How You Can Use it to Obtain Patents” was published on...

Value in Underutilized Design Patents

Design patent protection is distinct from utility patent protection. Design patents protect the ornamental features of an article of manufacture rather than its utilitarian features....

Diagnostic Peptide Panels Patent-Ineligible?

Oxford Immunotec Ltd. v. Qiagen, Inc. et al., pending in the U.S. District Court, D. Mass. (Case 1:15-cv-13124-NMG), likely has a long way to go before...

Update: From USPTO Patent Eligibility Guidelines

This is an update from our newsletter of January 2015. On July 30, 2015, the USPTO issued an update regarding the 2014 Interim Guidance on...

USPTO Introduces Expedited Patent Appeal Pilot

The USPTO is providing a temporary basis under which an appellant may have an ex parte appeal to the Patent Trial and Appeal Board (Board)...

Final Patent Term Adjustment Rules Issued

The USPTO issued final rules on January 9, 2015 implementing changes to the way in which Patent Term Adjustment (PTA) is calculated in viewof the recent Federal...

Updated Mayo/Myriad/Alice Patent Eligibility Interim Guidance

On December 16, 2014, the USPTO finally issued updated and significantly revised Interim Guidance to the Examiners for examination of patent claims for patent eligibility,...

Federal Circuit’s denial of rehearing Bristol-Myers Squibb v. Teva regarding Entecavir exposes potential issues regarding the utility of later found unexpected results for overcoming obviousness

In the earlier panel opinion, Entecavir was found obvious under the lead compound analysis over a structurally close compound 2’-CDG, which compound at the time...

New Book Regarding Patent Term Extensions: Authors Include MWZB Attorneys

MWZB is pleased to announce the publication of a new book on patent term extension. Patent term extension is a critical factor in protecting the...
1 2

Categories

Archive

MWZB Newsletter Signup

Subscribe
Confidential/Privileged Information MWZB is pleased that you would like to contact the firm. However, you should be aware that any information, documents and the like submitted in connection with this email message or otherwise via the firm’s website will not be treated as a privileged or confidential attorney/client communication unless and until the relationship is governed by an engagement letter. You are not a client of MWZB in the absence of such an engagement letter. If you understand and accept these terms and wish to proceed, please enter your email address below.

Newsletter Signup